Cipla’s arm incorporates subsidiary in Kingdom of Saudi Arabia

04 Mar 2026 Evaluate

Cipla’s wholly owned subsidiary -- Cipla (EU), UK, has incorporated a new wholly owned subsidiary named ‘Cipla Middle East Company’ in the Kingdom of Saudi Arabia, effective March 1, 2026. Cipla Middle East Company has been incorporated with the objective of establishing a legal entity for manufacturing and distribution of pharmaceutical products and hold marketing authorisations in KSA. 

Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).


Cipla Share Price

1312.65 -39.20 (-2.90%)
04-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.35
Dr. Reddys Lab 1291.15
Cipla 1312.65
Zydus Lifesciences 896.55
Lupin 2304.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×